MCM
XPH icon

Manchester Capital Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Manchester Capital Management’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-200
Closed -$8.63K – 1182
2024
Q1 		$8.63K Buy
+200
New +$8.62K ﹤0.01% 652

Other funds holding XPH

CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
EH
Equitable Holdings New York $16.7B AUM 24.23% 1-Year Est. Return
KWM
Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
Envestnet Portfolio Solutions
Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.28% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Manchester Capital Management's XPH Position: Q2 2024 in Review

Manchester Capital Management sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2024, closing a stake of 200 shares — an estimated $8.63K sold.

Manchester Capital Management first reported a position in XPH in Q1 2024 and held it in 1 quarter. The position peaked at $8.63K in Q1 2024. 71 funds tracked by Wall St. Rank hold XPH as of Q2 2024.

  • Manchester Capital Management reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q2 2024 after selling out during the quarter.
  • Manchester Capital Management sold 200 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2024, an estimated $8.63K.
  • Manchester Capital Management first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2024 and held it in 1 quarter.
  • Manchester Capital Management's State Street SPDR S&P Pharmaceuticals ETF position peaked at $8.63K in Q1 2024.
  • 71 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2024.

Based on Manchester Capital Management's 13F filing for Q2 2024, filed 8 Aug 2024.